News & Information
PHEN kicks off 2020 Daddy's Boys Tour
Using entertainment to educate about prostate cancer, PHEN will kick off its 2020 tour of the stage play "Daddy's Boys" on March 21st in Durham, NC at the Carolina Theater....
Understanding Today's Treatment Challenges
Dr. Carlton B. Barnswell presents at PHEN's January webcast on "Understanding Today's Treatment Challenges."
Dr. Carlton B. Barnswell presents at PHEN's January webcast on "Understanding Today's Treatment Challenges."
Regular exercise is important for good bone health.
It increases bone mass, makes bone stronger, maintains and improves muscle strength, coordination and balance. Thus reducing the risk of fractures from falls.
It increases bone mass, makes bone stronger, maintains and improves muscle strength, coordination and balance. Thus reducing the risk of fractures from falls.
A Small Number Of Men With Prostate Cancer Are 'Super Responders' to Immunotheraphy
Results from a new clinical trial have shown that some men with advanced prostate cancer can live for at least two more years on immunotherapy after exhausting all other treatment options...
Results from a new clinical trial have shown that some men with advanced prostate cancer can live for at least two more years on immunotherapy after exhausting all other treatment options...
Psychosocial Concerns Common After Prostate Cancer Treatment
Psychosocial problems that adversely affect quality of life are common among men after receiving treatment for prostate cancer, and they need help....
Psychosocial problems that adversely affect quality of life are common among men after receiving treatment for prostate cancer, and they need help....
Men Over 40 With BRCA2 Mutations Must Get Prostate Cancer Screening, Experts Say
Researchers have called for immediate action to recommend screening for prostate cancer for men with BRCA2 mutations over the age of 40.
Researchers have called for immediate action to recommend screening for prostate cancer for men with BRCA2 mutations over the age of 40.
Prostate Cancer Treatments
Keith Crawford, MD, PhD
PHEN Director of Clinical Trials
and Patient Education